ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Steglatro 5 mg, Filmtabletten - 98
66577002 MSD Merck Sharp & Dohme AG
Steglatro 5 mg, Filmtabletten18.10.2018
  18.10.2018
Ertugliflozin (A10BK04) 
WHO-DDD 
07.06.20.98
07.06.20. 
B  
Yes 
IPCI
134.36Yes
    
10 %162.55
7680665770024Synthetika
7596941 
Composition
ertugliflozinum 5 mg ut ertugliflozini l-pidolas 6.477 mg, cellulosum microcristallinum, lactosum monohydricum 29.841 mg, carboxymethylamylum natricum A corresp. natrium 0.13 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 0.84 mg, macrogolum 3350, triacetinum, E 171, E 172 (rubrum), pro compresso obducto.
Packungsbestandteile
Coated tablets 
 
Active AgentDose
Ertugliflozinum5 mg
BAG: Active AgentDose
Ertugliflozinum5 mg
 
Inactive agentsDoseadditional_information
(Rubrum)  
Carboxymethylamylum Natricum A  
Cellulosum Microcristallinum  
E 171 color.
E 172 color.
Hypromellosum Überzug
Lactose Monohydrate0.84 mg 
Macrogol3350  
Magnesii Stearas  
Pro Compresso Obducto  
Triacetinum  
 
Source
Data was imported : 07.05.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home